Genomic insights into tuberculosis

Nature Reviews Genetics

Volumn 15, Issue 5, 2014, Pages 307-320

  Galagan, James E ^a,b  

^a Boston University   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE ANTIGEN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENOME; BACTERIAL STRAIN; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOMICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; MOLECULAR EPIDEMIOLOGY; MORTALITY; MULTIDRUG RESISTANCE; MUTATION RATE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENICITY; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYSTEMS BIOLOGY; TREATMENT PLANNING; TUBERCULOSIS; ZOONOSIS;

MYCOBACTERIUM TUBERCULOSIS;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; GENOMICS; HUMANS; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; SYSTEMS BIOLOGY; TUBERCULOSIS;

EID: 84898811330     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg3664     Document Type: Review

References (184)

1. World Health Organization. Global Tuberculosis Control (WHO, 2010).
2. Russell, D. G. Mycobacterium tuberculosis: here today, and here tomorrow. Nature Rev. Mol. Cell Biol. 2, 569-577 (2001).
3. Russell, D. G. Who puts the tubercle in tuberculosis? Nature Rev. Microbiol. 5, 39-47 (2006).
4. Kaufmann, S. H. E. How can immunology contribute to the control of tuberculosis? Nature Rev. Immunol. 1, 20-30 (2001).
5. Parrish, N. M., Dick, J. D. & Bishai, W. R. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 6, 107-112 (1998).
6. Veyrier, F. J., Dufort, A. & Behr, M. A. The rise and fall of the Mycobacterium tuberculosis genome. Trends Microbiol. 19, 156-161 (2011).
7. Kapur, V., Whittam, T. S. & Musser, J. M. Is Mycobacterium tuberculosis 15, 000 years old? J. Infect. Dis. 170, 1348-1349 (1994).
8. Bates, J. H. & Stead, W. W. The history of tuberculosis as a global epidemic. Med. Clin. North Am. 77, 1205-1217 (1993).
9. Cole, S. T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544 (1998)
10. Erratum 396, 190 (1998).
11. Behr, M. A. et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284, 1520-1523 (1999).
12. Gordon, S. V. et al. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol. Microbiol. 32, 643-655 (1999).
13. Brosch, R. et al. Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain. Infect. Immun. 67, 5768-5774 (1999).
14. Brosch, R. et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl Acad. Sci. USA 99, 3684-3689 (2002).
15. Mostowy, S. & Behr, M. A. The origin and evolution of Mycobacterium tuberculosis. Clin. Chest Med. 26, 207-216 (2005).
16. van Soolingen, D. et al. A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int. J. Syst. Bacteriol. 47, 1236-1245 (1997).
17. Koeck, J. L. et al. Clinical characteristics of the smooth tubercle bacilli 'Mycobacterium canettii' infection suggest the existence of an environmental reservoir. Clin. Microbiol. Infect. 17, 1013-1019 (2011).
18. Fabre, M. et al. Molecular characteristics of "Mycobacterium canettii" the smooth Mycobacterium tuberculosis bacilli. Infect. Genet. Evol. 10, 1165-1173 (2010).
19. Gutierrez, M. C. et al. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog. 1, e5 (2005).
20. Supply, P. et al. Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nature Genet. 45, 172-179 (2013).
21. Gagneux, S. Genetic diversity in Mycobacterium tuberculosis. Curr. Top. Microbiol. Immunol. 374, 1-25 (2013).
22. Biet, F. et al. Inter-and intra-subtype genotypic differences that differentiate Mycobacterium avium subspecies paratuberculosis strains. BMC Microbiol. 12, 264 (2012).
23. Turenne, C. Y., Wallace, R. Jr & Behr, M. A. Mycobacterium avium in the postgenomic era. Clin. Microbiol. Rev. 20, 205-229 (2007).
24. Turenne, C. Y., Collins, D. M., Alexander, D. C. & Behr, M. A. Mycobacterium avium subsp. paratuberculosis and M. avium subsp. avium are independently evolved pathogenic clones of a much broader group of M. avium organisms. J. Bacteriol. 190, 2479-2487 (2008).
25. Sreevatsan, S. et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl Acad. Sci. USA 94, 9869-9874 (1997).
26. Musser, J. M., Amin, A. & Ramaswamy, S. Negligible genetic diversity of Mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure. Genetics 155, 7-16 (2000).
27. Comas, I. et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nature Genet. 42, 498-503 (2010).
28. Comas, I. et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nature Genet. 45, 1176-1182 (2013).
29. Coscolla, M. & Gagneux, S. Does M. tuberculosis genomic diversity explain disease diversity? Drug Discov. Today Dis. Mech. 7, e43-e59 (2010).
30. Wirth, T. et al. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog. 4, e1000160 (2008).
31. Brudey, K. et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 6, 23 (2006).
32. Mathema, B., Kurepina, N. E., Bifani, P. J. & Kreiswirth, B. N. Molecular epidemiology of tuberculosis: current insights. Clin. Microbiol. Rev. 19, 658-685 (2006).
33. Hershberg, R. et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol. 6, e311 (2008).
34. Mostowy, S., Cousins, D., Brinkman, J., Aranaz, A. & Behr, M. A. Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J. Infect. Dis. 186, 74-80 (2002).
35. Gagneux, S. & Small, P. M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 7, 328-337 (2007).
36. Gagneux, S. et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 103, 2869-2873 (2006).
37. Behr, M. A. Mycobacterium du jour: what's on tomorrow's menu? Microbes Infect. 10, 968-972 (2008).
38. Firdessa, R. et al. Mycobacterial lineages causing pulmonary and extrapulmonary tuberculosis, Ethiopia. Emerg. Infect. Dis. 19, 460-463 (2013).
39. Garnier, T. et al. The complete genome sequence of Mycobacterium bovis. Proc. Natl Acad. Sci. USA 100, 7877-7882 (2003).
40. Prodinger, W. M. et al. Characterization of Mycobacterium caprae isolates from Europe by mycobacterial interspersed repetitive unit genotyping. J. Clin. Microbiol. 43, 4984-4992 (2005).
41. Cousins, D. V. et al. Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp. nov. Int. J. Syst. Evol. Microbiol. 53, 1305-1314 (2003).
42. Gagneux, S. Host-pathogen coevolution in human tuberculosis. Phil. Trans. R. Soc. B 367, 850-859 (2012).
43. Pepperell, C. S. et al. The role of selection in shaping diversity of natural M. tuberculosis populations. PLoS Pathog. 9, e1003543 (2013).
44. Coscolla, M. et al. Novel Mycobacterium tuberculosis complex isolate from a wild chimpanzee. Emerg. Infect. Dis. 19, 969-976 (2013).
45. Cousins, D. V., Peet, R. L., Gaynor, W. T., Williams, S. N. & Gow, B. L. Tuberculosis in imported hyrax (Procavia capensis) caused by an unusual variant belonging to the Mycobacterium tuberculosis complex. Vet. Microbiol. 42, 135-145 (1994).
46. Alexander, K. A. et al. Novel Mycobacterium tuberculosis complex pathogen, M. mungi. Emerg. Infect. Dis. 16, 1296-1299 (2010).
47. Udwadia, Z. & Vendoti, D. Totally drug-resistant tuberculosis (TDR-tuberculosis) in India: every dark cloud has a silver lining. J. Epidemiol. Commun. Health 67, 471-472 (2013).
48. Migliori, G. B., De Iaco, G., Besozzi, G., Centis, R. & Cirillo, D. M. First tuberculosis cases in Italy resistant to all tested drugs. Euro Surveill 12, E070517.1 (2007).
49. Klopper, M. et al. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerg. Infect. Dis. 19, 449-455 (2013).
50. Velayati, A. A. et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest 136, 420-425 (2009).
51. Ohno, S. Evolution by Gene Duplication (Springer-Verlag, 1970).
52. Sandegren, L. & Andersson, D. I. Bacterial gene amplification: implications for the evolution of antibiotic resistance. Nature Rev. Microbiol. 7, 578-588 (2009).
53. Ochman, H., Lawrence, J. G. & Groisman, E. A. Lateral gene transfer and the nature of bacterial innovation. Nature 405, 299-304 (2000).
54. Boucher, Y. et al. Lateral gene transfer and the origins of prokaryotic groups. Annu. Rev. Genet. 37, 283-328 (2003).
55. Darling, A. E., Miklos, I. & Ragan, M. A. Dynamics of genome rearrangement in bacterial populations. PLoS Genet. 4, e1000128 (2008).
56. Kinsella, R. J., Fitzpatrick, D. A., Creevey, C. J. & McInerney, J. O. Fatty acid biosynthesis in Mycobacterium tuberculosis: lateral gene transfer, adaptive evolution, and gene duplication. Proc. Natl Acad. Sci. USA 100, 10320-10325 (2003).
57. Jang, J., Becq, J., Gicquel, B., Deschavanne, P. & Neyrolles, O. Horizontally acquired genomic islands in the tubercle bacilli. Trends Microbiol. 16, 303-308 (2008).
58. Becq, J. et al. Contribution of horizontally acquired genomic islands to the evolution of the tubercle bacilli. Mol. Biol. Evol. 24, 1861-1871 (2007).
59. Stinear, T. P. et al. Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res. 18, 729-741 (2008).
60. Veyrier, F. J., Dufort, A. & Behr, M. A. The rise and fall of the Mycobacterium tuberculosis genome. Trends Microbiol. 19, 156-161 (2011).
61. Supply, P. et al. Linkage disequilibrium between minisatellite loci supports clonal evolution of Mycobacterium tuberculosis in a high tuberculosis incidence area. Mol. Microbiol. 47, 529-538 (2003).
62. Hirsh, A. E., Tsolaki, A. G., DeRiemer, K., Feldman, M. W. & Small, P. M. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc. Natl Acad. Sci. USA 101, 4871-4876 (2004).
63. Namouchi, A., Didelot, X., Schock, U., Gicquel, B. & Rocha, E. P. After the bottleneck: genome-wide diversification of the Mycobacterium tuberculosis complex by mutation, recombination, and natural selection. Genome Res. 22, 721-734 (2012).
64. Tsolaki, A. G. et al. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc. Natl Acad. Sci. USA 101, 4865-4870 (2004).
65. Ho, T. B., Robertson, B. D., Taylor, G. M., Shaw, R. J. & Young, D. B. Comparison of Mycobacterium tuberculosis genomes reveals frequent deletions in a 20 kb variable region in clinical isolates. Yeast 17, 272-282 (2000).
66. Sampson, S. L., Richardson, M., Van Helden, P. D. & Warren, R. M. IS6110-mediated deletion polymorphism in isogenic strains of Mycobacterium tuberculosis. J. Clin. Microbiol. 42, 895-898 (2004).
67. Sampson, S. L. et al. IS6110-mediated deletion polymorphism in the direct repeat region of clinical isolates of Mycobacterium tuberculosis. J. Bacteriol. 185, 2856-2866 (2003).
68. Alexander, D. C., Turenne, C. Y. & Behr, M. A. Insertion and deletion events that define the pathogen Mycobacterium avium subsp. paratuberculosis. J. Bacteriol. 191, 1018-1025 (2009).
69. Domenech, P., Kolly, G. S., Leon-Solis, L., Fallow, A. & Reed, M. B. Massive gene duplication event among clinical isolates of the Mycobacterium tuberculosis W/Beijing family. J. Bacteriol. 192, 4562-4570 (2010).
70. Weiner, B. et al. Independent large scale duplications in multiple M. tuberculosis lineages overlapping the same genomic region. PLoS ONE 7, e26038 (2012).
71. McDonough, M. A. & Butterton, J. R. Spontaneous tandem amplification and deletion of the shiga toxin operon in Shigella dysenteriae 1. Mol. Microbiol. 34, 1058-1069 (1999).
72. Bennett, P. M. Genome plasticity: insertion sequence elements, transposons and integrons, and DNA rearrangement. Methods Mol. Biol. 266, 71-113 (2004).
73. Ford, C. B. et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nature Genet. 43, 482-486 (2011).
74. Ford, C. B. et al. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nature Genet. 45, 784-790 (2013).
75. McGrath, M., Gey van Pittius, N. C., van Helden, P. D., Warren, R. M. & Warner, D. F. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 69, 292-302 (2013).
76. Gill, W. P. et al. A replication clock for Mycobacterium tuberculosis. Nature Med. 15, 211-214 (2009).
77. Munoz-Elias, E. J. et al. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect. Immun. 73, 546-551 (2005).
78. Cohen, N. R., Lobritz, M. A. & Collins, J. J. Microbial persistence and the road to drug resistance. Cell Host Microbe 13, 632-642 (2013).
79. Kohanski, M. A., DePristo, M. A. & Collins, J. J. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol. Cell 37, 311-320 (2010).
80. Dwyer, D. J., Kohanski, M. A. & Collins, J. J. Role of reactive oxygen species in antibiotic action and resistance. Curr. Opin. Microbiol. 12, 482-489 (2009).
81. Ioerger, T. R. et al. Genome analysis of multi-and extensively-drug- resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS ONE 4, e7778 (2009).
82. Ioerger, T. R. et al. The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa. BMC Genomics 11, 670 (2010).
83. Mariam, S. H., Werngren, J., Aronsson, J., Hoffner, S. & Andersson, D. I. Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatment. PLoS ONE 6, e21147 (2011).
84. Casali, N. et al. Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res. 22, 735-745 (2012).
85. Sun, G. et al. Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J. Infect. Dis. 206, 1724-1733 (2012).
86. Fortune, S. M. The surprising diversity of Mycobacterium tuberculosis: change you can believe in. J. Infect. Dis. 206, 1642-1644 (2012).
87. Nachega, J. B. & Chaisson, R. E. Tuberculosis drug resistance: a global threat. Clin. Infect. Dis. 36, S24-S30 (2003).
88. Cirz, R. T. & Romesberg, F. E. Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria. Antimicrob. Agents Chemother. 50, 220-225 (2006).
89. Boshoff, H. I., Reed, M. B., Barry, C. E., 3rd & Mizrahi, V. DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 11 3, 183-193 (2003).
90. Drobniewski, F. et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 293, 2726-2731 (2005).
91. Johnson, R. et al. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int. J. Tuberc Lung Dis. 14, 119-121 (2010).
92. Cohen-Bacrie, S. et al. Imported extensively drug-resistant Mycobacterium tuberculosis Beijing genotype, Marseilles, France, 2011. Euro Surveill 16, 19846 (2011).
93. Kubica, T. et al. The Beijing genotype is a major cause of drug-resistant tuberculosis in Kazakhstan. Int. J. Tuberc Lung Dis. 9, 646-653 (2005).
94. Mestre, O. et al. Phylogeny of Mycobacterium tuberculosis Beijing strains constructed from polymorphisms in genes involved in DNA replication, recombination and repair. PLoS ONE 6, e16020 (2011).
95. Muller, B., Borrell, S., Rose, G. & Gagneux, S. The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. Trends Genet. 29, 160-169 (2013).
96. Gagneux, S. et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312, 1944-1946 (2006).
97. Billington, O. J., McHugh, T. D. & Gillespie, S. H. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43, 1866-1869 (1999).
98. Davies, A. P. et al. Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. J. Infect. 41, 184-187 (2000).
99. Pym, A. S., Saint-Joanis, B. & Cole, S. T. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect. Immun. 70, 4955-4960 (2002).
100. Sander, P. et al. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother. 46, 1204-1211 (2002).
101. Bottger, E. C., Springer, B., Pletschette, M. & Sander, P. Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nature Med. 4, 1343-1344 (1998).
102. Comas, I. et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nature Genet. 44, 106-110 (2011).
103. de Vos, M. et al. Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission. Antimicrob. Agents Chemother. 57, 827-832 (2013).
104. Galagan, J. E. et al. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 499, 178-183 (2013).
105. Robertson, G. et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nature Methods 4, 651-657 (2007).
106. Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560 (2007).
107. Johnson, D. S., Mortazavi, A., Myers, R. M. & Wold, B. Genome-wide mapping of in vivo protein-DNA interactions. Science 316, 1497-1502 (2007).
108. Galagan, J., Lyubetskaya, A. & Gomes, A. ChIP-seq and the complexity of bacterial transcriptional regulation. Curr. Top. Microbiol. Immunol. 363, 43-68 (2013).
109. Jaini, S. et al. Molecular Genetics of Mycobacteria 2nd edn (eds Hatfull, G. & Jacobs, W. R. Jr.) (ASM Press, in the press).
110. Farnham, P. J. Insights from genomic profiling of transcription factors. Nature Rev. Genet. 10, 605-616 (2009).
111. Ideker, T. & Sharan, R. Protein networks in disease. Genome Res. 18, 644 (2013).
112. Alon, U. Network motifs: theory and experimental approaches. Nature Rev. Genet. 8, 450-461 (2007).
113. Guelzim, N., Bottani, S., Bourgine, P. & Kepes, F. Topological and causal structure of the yeast transcriptional regulatory network. Nature Genet. 31, 60-63 (2002).
114. Alon, U. An Introduction to Systems Biology: Design Principles of Biological Circuits (Chapman and Hall/CRC, 2006).
115. Levine, J. H., Lin, Y. & Elowitz, M. B. Functional roles of pulsing in genetic circuits. Science 342, 1193-1200 (2013).
116. Bennett, M. R. & Hasty, J. Microfluidic devices for measuring gene network dynamics in single cells. Nature Rev. Genet. 10, 628-638 (2009).
117. Yosef, N. & Regev, A. Impulse control: temporal dynamics in gene transcription. Cell 144, 886-896 (2011).
118. Wakamoto, Y. et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science 339, 91-95 (2013).
119. Singh, A. et al. Mycobacterium tuberculosis WhiB3 maintains redox homeostasis by regulating virulence lipid anabolism to modulate macrophage response. PLoS Pathog. 5, e1000545 (2009).
120. Schnappinger, D. et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198, 693-704 (2003).
121. Rohde, K., Yates, R. M., Purdy, G. E. & Russell, D. G. Mycobacterium tuberculosis and the environment within the phagosome. Immunol. Rev. 219, 37-54 (2007).
122. Yang, X., Nesbitt, N. M., Dubnau, E., Smith, I. & Sampson, N. S. Cholesterol metabolism increases the metabolic pool of propionate in Mycobacterium tuberculosis. Biochemistry 48, 3819-3821 (2009).
123. Kendall, S. L. et al. Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2. Microbiology 156, 1362-1371 (2010).
124. Kendall, S. L. et al. A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis. Mol. Microbiol. 65, 684-699 (2007).
125. Nesbitt, N. M. et al. A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol. Infect. Immun. 78, 275-282 (2010).
126. Uhia, I., Galan, B., Medrano, F. J. & Garcia, J. L. Characterization of the KstR-dependent promoter of the first step of cholesterol degradative pathway in Mycobacterium smegmatis. Microbiology 157, 2670-2680 (2011).
127. Munoz-Elias, E. J. & McKinney, J. D. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nature Med. 11, 638-644 (2005).
128. Daniel, J., Maamar, H., Deb, C., Sirakova, T. D. & Kolattukudy, P. E. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog. 7, e1002093 (2011).
129. Low, K. L. et al. Triacylglycerol utilization is required for regrowth of in vitro hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-Guerin. J. Bacteriol. 191, 5037-5043 (2009).
130. Peyron, P. et al. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4, e1000204 (2008).
131. Russell, D. G., Cardona, P. J., Kim, M. J., Allain, S. & Altare, F. Foamy macrophages and the progression of the human tuberculosis granuloma. Nature Immunol. 10, 943-948 (2009).
132. 2 and nitric oxide via its [4Fe-4S] cluster and is essential for nutrient starvation survival. Proc. Natl Acad. Sci. USA 104, 11562-11567 (2007).
133. Russell, D. G. The evolutionary pressures that have molded Mycobacterium tuberculosis into an infectious adjuvant. Curr. Opin. Microbiol. 16, 78-84 (2013).
134. Russell, D. G. Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol. Rev. 240, 252-268 (2011).
135. Russell, D. G., Mwandumba, H. C. & Rhoades, E. E. Mycobacterium and the coat of many lipids. J. Cell Biol. 158, 421-426 (2002).
136. Russell, D. G. et al. Mycobacterium tuberculosis wears what it eats. Cell Host Microbe 8, 68-76 (2010).
137. Ehlers, S. & Schaible, U. E. The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front. Immunol. 3, 411 (2012).
138. Comas, I. & Gagneux, S. A role for systems epidemiology in tuberculosis research. Trends Microbiol. 19, 492-500 (2011).
139. Pawlowski, A., Jansson, M., Skold, M., Rottenberg, M. E. & Kallenius, G. Tuberculosis and HIV co-infection. PLoS Pathog. 8, e1002464 (2012).
140. Dooley, K. E. & Chaisson, R. E. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect. Dis. 9, 737-746 (2009).
141. Brothwell, D. R. & Sandison, A. T. Diseases in Antiquity: a Survey of the Diseases, Injuries, and Surgery of Early Populations (C. C. Thomas, 1967).
142. Prasad, P. V. General medicine in Atharvaveda with special reference to Yaksma (consumption/tuberculosis). Bull. Indian Inst. Hist. Med. Hyderabad 32, 1-14 (2002).
143. Daniel, V. S. & Daniel, T. M. Old Testament biblical references to tuberculosis. Clin. Infect. Dis. 29, 1557-1558 (1999).
144. Roberts, C. A. & Buikstra, J. E. The Bioarchaeology of Tuberculosis: a Global View on a Reemerging Disease (Univ. Press of Florida, 2008).
145. Donoghue, H. D. et al. Tuberculosis: from prehistory to Robert Koch, as revealed by ancient DNA. Lancet Infect. Dis. 4, 584-592 (2004).
146. Zink, A. et al. Molecular history of tuberculosis from ancient mummies and skeletons. Int. J. Osteoarchaeol. 17, 380 (2007).
147. Bouwman, A. S. et al. Genotype of a historic strain of Mycobacterium tuberculosis. Proc. Natl Acad. Sci. 109, 18511-18516 (2012)
148. Zimmerman, M. R. Pulmonary and osseous tuberculosis in an Egyptian mummy. Bull. N. Y. Acad. Med. 55, 604-608 (1979).
149. Crubezy, E. et al. Identification of Mycobacterium DNA in an Egyptian Pott's disease of 5, 400 years old. C. R. Acad. Sci. III 321, 941-951 (1998).
150. Zink, A., Haas, C. J., Reischl, U., Szeimies, U. & Nerlich, A. G. Molecular analysis of skeletal tuberculosis in an ancient Egyptian population. J. Med. Microbiol. 50, 355-366 (2001).
151. Zink, A. R., Grabner, W., Reischl, U., Wolf, H. & Nerlich, A. G. Molecular study on human tuberculosis in three geographically distinct and time delineated populations from ancient Egypt. Epidemiol. Infect. 130, 239-249 (2003).
152. Zink, A. R. et al. Characterization of Mycobacterium tuberculosis complex DNAs from Egyptian mummies by spoligotyping. J. Clin. Microbiol. 41, 359-367 (2003).
153. Nerlich, A. G. & Losch, S. Paleopathology of human tuberculosis and the potential role of climate. Interdiscip Perspect. Infect. Dis. 2009, 437187 (2009).
154. Nicklisch, N. et al. Rib lesions in skeletons from early neolithic sites in Central Germany: on the trail of tuberculosis at the onset of agriculture. Am. J. Phys. Anthropol. 149, 391-404 (2012).
155. Formicola, V., Milanesi, Q. & Scarsini, C. Evidence of spinal tuberculosis at the beginning of the fourth millennium bc from Arene Candide cave (Liguria, Italy). Am. J. Phys. Anthropol. 72, 1-6 (1987).
156. Sager, P., Schalimtzer, M. & Moller-Christensen, V. A case of spondylitis tuberculosa in the Danish Neolithic Age. Dan Med. Bull. 19, 176-180 (1972).
157. Fusegawa, H. et al. Outbreak of tuberculosis in a 2000-year-old Chinese population. Kansenshogaku Zasshi 77, 146-149 (2003).
158. Hershkovitz, I. et al. Detection and molecular characterization of 9, 000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean. PLoS ONE 3, e3426 (2008).
159. Klaus, H. et al. Tuberculosis on the north coast of Peru: skeletal and molecular paleopathology of late pre-Hispanic and postcontact mycobacterial disease. J. Archaeol. Sci. 37, 2587 (2010).
160. Salo, W. L., Aufderheide, A. C., Buikstra, J. & Holcomb, T. A. Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy. Proc. Natl Acad. Sci. USA 91, 2091-2094 (1994).
161. Arriaza, B. T., Salo, W., Aufderheide, A. C. & Holcomb, T. A. Pre-Columbian tuberculosis in northern Chile: molecular and skeletal evidence. Am. J. Phys. Anthropol. 98, 37-45 (1995).
162. Rothschild, B. M. & Martin, L. D. Did ice-age bovids spread tuberculosis? Naturwissenschaften 93, 565-569 (2006).
163. Rothschild, B. M. & Laub, R. Hyperdisease in the late Pleistocene: validation of an early 20th century hypothesis. Naturwissenschaften 93, 557-564 (2006).
164. Borgdorff, M. W. & van Soolingen, D The re-emergence of tuberculosis: what have we learnt from molecular epidemiology? Clin. Microbiol. Infect. 19, 889-901 (2013).
165. Gori, A. et al. Spoligotyping and Mycobacterium tuberculosis. Emerg. Infect. Dis. 11, 1242-1248 (2005).
166. Gori, A. et al. Comparison between spoligotyping and IS6110 restriction fragment length polymorphisms in molecular genotyping analysis of Mycobacterium tuberculosis strains. Mol. Cell Probes 19, 236-244 (2005).
167. Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709-1712 (2007).
168. Marraffini, L. A. & Sontheimer, E. J. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322, 1843-1845 (2008).
169. Schurch, A. C. & van Soolingen, D. DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencing. Infect. Genet. Evol. 12, 602-609 (2012).
170. McAdam, R. A. et al. Characterization of a Mycobacterium tuberculosis insertion sequence belonging to the IS3 family. Mol. Microbiol. 4, 1607-1613 (1990).
171. Coros, A., DeConno, E. & Derbyshire, K. M. IS6110, a Mycobacterium tuberculosis complex-specific insertion sequence, is also present in the genome of Mycobacterium smegmatis, suggestive of lateral gene transfer among mycobacterial species. J. Bacteriol. 190, 3408-3410 (2008).
172. Supply, P. et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 44, 4498-4510 (2006).
173. Djelouadji, Z., Arnold, C., Gharbia, S., Raoult, D. & Drancourt, M. Multispacer sequence typing for Mycobacterium tuberculosis genotyping. PLoS ONE 3, e2433 (2008).
174. Maccallum, I. et al. ALLPATHS 2: small genomes assembled accurately and with high continuity from short paired reads. Genome Biol. 10, R103 (2009).
175. Butler, J. et al. ALLPATHS: de novo assembly of whole-genome shotgun microreads. Genome Res. 18, 810-820 (2008).
176. Zerbino, D. R. Using the Velvet de novo assembler for short-read sequencing technologies. Curr. Protoc. Bioinformatics 31, 11.5.1-11.5.12 (2010).
177. Denisov, G. et al. Consensus generation and variant detection by Celera Assembler. Bioinformatics 24, 1035-1040 (2008).
178. Zhang, T., Luo, Y., Chen, Y., Li, X. & Yu, J. BIGrat: a repeat resolver for pyrosequencing-based re-sequencing with Newbler. BMC Res. Notes 5, 567 (2012).
179. Quail, M. A. et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics 13, 341 (2012).
180. Bashir, A. et al. A hybrid approach for the automated finishing of bacterial genomes. Nature Biotech. 30, 701-707 (2012).
181. Koren, S. et al. Reducing assembly complexity of microbial genomes with single-molecule sequencing. Genome Biol. 14, R101 (2013).
182. Walker, T. M. et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect. Dis. 13, 137-146 (2013).
183. Gardy, J. L. et al. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N. Engl. J. Med. 364, 730-739 (2011).
184. Bryant, J. M. et al. Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study. Lancet Respir. Med. 1, 786-792 (2013).